Detalhe da pesquisa
1.
Mineralocorticoid receptor antagonism improves diastolic dysfunction in chronic kidney disease in mice.
J Mol Cell Cardiol
; 121: 124-133, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29981797
2.
Cardiomyocyte-specific overexpression of oestrogen receptor ß improves survival and cardiac function after myocardial infarction in female and male mice.
Clin Sci (Lond)
; 130(5): 365-76, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26608078
3.
Cardiac aldosterone overexpression prevents harmful effects of diabetes in the mouse heart by preserving capillary density.
FASEB J
; 23(7): 2176-85, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19255254
4.
Effects of aldosterone on coronary function.
Pharmacol Rep
; 61(1): 58-66, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19307693
5.
Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Protects Against Acute Kidney Injury-Mediated Chronic Kidney Disease: Role of Oxidative Stress.
Hypertension
; 69(5): 870-878, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28320854
6.
Aldosterone promotes cardiac endothelial cell proliferation in vivo.
J Am Heart Assoc
; 4(1): e001266, 2015 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25564371
7.
Endothelial Gata5 transcription factor regulates blood pressure.
Nat Commun
; 6: 8835, 2015 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26617239
8.
Cardiomyocyte-specific Estrogen Receptor Alpha Increases Angiogenesis, Lymphangiogenesis and Reduces Fibrosis in the Female Mouse Heart Post-Myocardial Infarction.
J Cell Sci Ther
; 5(1): 153, 2014 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24977106
9.
The diuretic torasemide does not prevent aldosterone-mediated mineralocorticoid receptor activation in cardiomyocytes.
PLoS One
; 8(9): e73737, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24040049
10.
Aldosterone-specific activation of cardiomyocyte mineralocorticoid receptor in vivo.
Hypertension
; 61(2): 361-7, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23297371
11.
Aldosterone, mineralocorticoid receptor, and heart failure.
Mol Cell Endocrinol
; 350(2): 266-72, 2012 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21784127
12.
The epidermal growth factor receptor is involved in angiotensin II but not aldosterone/salt-induced cardiac remodelling.
PLoS One
; 7(1): e30156, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22291909
13.
Neutrophil gelatinase-associated lipocalin is a novel mineralocorticoid target in the cardiovascular system.
Hypertension
; 59(5): 966-72, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22469622
14.
Epidermal growth factor receptor mediates the vascular dysfunction but not the remodeling induced by aldosterone/salt.
Hypertension
; 57(2): 238-44, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21199998
15.
Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure.
Am J Physiol Heart Circ Physiol
; 296(2): H435-41, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19074674
16.
Cross-talk between mineralocorticoid and angiotensin II signaling for cardiac remodeling.
Hypertension
; 52(6): 1060-7, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18981328
17.
Eplerenone administration has beneficial effect on hepatic paraoxonase 1 activity in diabetic mice.
Atherosclerosis
; 208(1): 26-7, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19651407